(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid;(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid;(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid
• 化学式: C44H66O4
• 分子量: 659.0
• InChiKey: BWNXGTOWNOGNQF-KSWFHQNMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  13.32
• 重原子数：
  48
• 可旋转键数：
  29
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS
  申请人：Remmereit, Jan

  公开号：EP2983658A1

  公开（公告）日：2016-02-17
• EP2986148A2
  申请人：——

  公开号：EP2986148A2

  公开（公告）日：2016-02-24
• [EN] LIPID COMPOSITIONS CONTAINING BIOACTIVE FATTY ACIDS<br/>[FR] COMPOSITIONS LIPIDIQUES CONTENANT DES ACIDES GRAS BIOACTIFS
  申请人：REMMEREIT JAN

  公开号：WO2014143614A1

  公开（公告）日：2014-09-18

  Provided herein is technology relating to lipid compositions containing bioactive fatty acids and particularly, but not exclusively, to compositions and methods related to the production and use of structured lipid compositions containing sciadonic and/or pinoleic acid alone or in combination with other bioactive fatty acids including, but not limited to, eicosapentaenoic acid, docosahexaenoic acid, conjugated linoleic acid, and non-β-oxidizable fatty acid analogues such as tetradecylthioacetic acid.
• [EN] COMPOSITIONS COMPRISING DOCOSAPENTAENOIC ACID AND METHODS OF USE<br/>[FR] COMPOSITIONS COMPRENANT DE L'ACIDE DOCOSAPENTAÉNOÏQUE ET PROCÉDÉS D'UTILISATION
  申请人：MATINAS BIOPHARMA INC

  公开号：WO2014165190A2

  公开（公告）日：2014-10-09

  Orally administrable composition comprising fatty acids comprising docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). The compositions can be used for the treatment or prophylaxis of a variety of conditions, including liver-related conditions.
• [EN] OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSITIONS D'ACIDE OMÉGA-3 PENTAÉNOÏQUE ET PROCÉDÉS D'UTILISATION
  申请人：MATINAS BIOPHARMA INC

  公开号：WO2014158256A1

  公开（公告）日：2014-10-02

  Orally administrable composition comprising fatty acids copmrisingomega-3-fatty acids, salts or derivatives thereof are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, CNS, inflammatory, and other diseases/conditions or risk factors therefore. The present invention relates to omega-3 fatty acid compositions, and methods of treating, preventing, reducing the occurrence of, and improving symptoms associated with inflammatory conditions.